Order Article Reprints

Taniguchi K, Ando Y, Kobayashi M, Toba S, Nobori H, Sanaki T, Noshi T, Kawai M, Yoshida R, Sato A, et al. Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection. Viruses. 2022; 14(1):111. https://doi.org/10.3390/v14010111

Taniguchi, Keiichi, Yoshinori Ando, Masanori Kobayashi, Shinsuke Toba, Haruaki Nobori, Takao Sanaki, Takeshi Noshi, Makoto Kawai, Ryu Yoshida, Akihiko Sato, and et al. 2022. "Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection" Viruses 14, no. 1: 111. https://doi.org/10.3390/v14010111

Taniguchi, K., Ando, Y., Kobayashi, M., Toba, S., Nobori, H., Sanaki, T., Noshi, T., Kawai, M., Yoshida, R., Sato, A., Shishido, T., Naito, A., Matsuno, K., Okamatsu, M., Sakoda, Y., & Kida, H. (2022). Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection. Viruses, 14(1), 111. https://doi.org/10.3390/v14010111